Osthole ameliorates myonecrosis caused by Clostridium perfringens type A infection in mice
作者机构:National Key Laboratory of Veterinary Public Health and SafetyCollege of Veterinary MedicineChina Agricultural UniversityBeijing 100193China Guangdong Laboratory for Lingnan Modern AgricultureGuangzhou 510642China
出 版 物:《One Health Advances》 (全健康进展(英文))
年 卷 期:2023年第1卷第1期
页 面:52-61页
学科分类:1008[医学-中药学(可授医学、理学学位)] 1006[医学-中西医结合] 100602[医学-中西医结合临床] 10[医学]
基 金:funded by Laboratory of Lingnan Modern Agriculture Project(Award number NT2021006) supported by the National Natural Science Foundation of China(Award number 32102724) Pinduoduo-China Agricultural University Research Fund(No.PC2023A01002)
主 题:C.perfringens Myonecrosis Osthole Nrf2/HO-1 pathway NF-κB pathway
摘 要:This study aimed to investigate the protective effect of the nature product osthole(OST)against Clostridium perfrin-gens type A infection-caused myonecrosis in a mouse *** mice were divided into(1)control,(2)infected,(3)OST50 and(4)OST100 treatment *** the infected groups,mice were intramuscularly injected with 1×10^(8) CFU of *** per day for 6 *** in the OST50 and OST100 groups were administrated intraperitoneally with OST at the doses of 50 or 100 mg/kg per day post *** *** results showed that *** infection caused marked necrosis and inflammatory cell infiltration in the muscle tissues of *** in the OST50 and OST100 treatment groups displayed significantly attenuated *** infection-induced lipid peroxida-tion,oxidative stress,and apoptosis in their muscle ***,OST treatment significantly downregulated the expressions of NF-κB,IL-1β,and TNF-αmRNA and protein levels,while concomitantly upregulating the expressions of Nrf2 and HO-1 mRNA and *** treatments also inhibited the expression of phosphorylation(p)-p38,p-mTOR,and p-Erk1/2 proteins,and upregulated LC3II and Beclin1 *** summary,our results reveal that OST therapy confers a protective effect against *** infection-induced oxidative stress and inflammation in muscle tissue,via activation of Nrf2/HO-1 and autophagy pathways and inhibition of p38,Erk1/2 and NF-κB pathways.